Your research can change the world
More on impact ›
The Inflammatory Eye Diseases section publishes high-quality applied and translational research that covers a broad range across all aspects of intraocular ocular inflammatory diseases and related uveitides; endophthalmitis; orbital inflammations and scleritis of infectious, non-infectious, autoimmune and other pathogenesis.
Intraocular inflammatory disorders are major causes of loss of vision through various mechanisms, including complications associated with medical and surgical interventions. Given the wide spectrum of these disorders, the Inflammatory Eye Diseases section publishes high-quality applied and translational research that covers a broad range – across all aspects of intraocular ocular inflammatory diseases and related uveitides; endophthalmitis; orbital inflammations and scleritis of infectious, non-infectious, autoimmune and other pathogenesis.
Within the field of ocular inflammation, we are soliciting papers that show significant advances in infectious and autoimmune pathogenesis, drug delivery, ocular inflammations relevant to systemic diseases including pulmonary diseases, rheumatologic and dermatologic disorders, and other fields of medicine. Also, being solicited are papers with recent advances in metagenomic next-generation sequencing in the diagnosis of infectious etiology, bioengineering and Artificial Intelligence (AI), translational research. Topics of interest include, but are not limited to, the following:
· Geographic variation and epidemiology of uveitis and related ocular inflammations
· Evolving Molecular and immunologic approaches in etiologic diagnosis
· Therapeutic agents induced intraocular inflammations
· Imaging and biomarkers in diagnosis and management
· Recent advances in therapeutic intervention, immunomodulatory agents, biologicals
· Drug delivery, Gene therapy, Precision medicine
· Telehealth and AI
· Ocular fluids and tissue analysis and surgical interventions
It is preferred that studies should contribute insights into pathogenesis or underlying mechanism(s) of clinical features and findings, showcase clinical significance, and provide methods in prevention and minimizing loss of vision in patients with eye inflammatory diseases. Fundamental and translational research relevant to ocular and orbital inflammation is encouraged. Studies on optic nerve do not fall within the scope of this section and should be submitted to sister Frontiers journal, Frontiers in Neurology (Neuro-ophthalmology section) and Frontiers in Medicine.
Indexed in: Google Scholar, CrossRef, CLOCKSS, OpenAIRE
Inflammatory Eye Diseases welcomes submissions of the following article types: Brief Research Report, Case Report, Classification, Clinical Trial, Correction, Data Report, Editorial, Erratum, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Inflammatory Eye Diseases, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact Ophthalmology.firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com